low dose semaglutide for inflammation Anti-inflammatory benefits of semaglutide: State of the art Beyond Weight Loss: How GLP-1

Reduces Risk of Chronic Kidney Disease Progression- For adults with T2D and CKD, to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death

Unwanted hair is managed with temporary or long-term methods like shaving, waxing, or laser

Short-chain fatty acids in nonalcoholic fatty liver disease: new prospects for short-chain fatty acids as therapeutic targets

DOI 10.1016/S0140-6736(22)02033-5 Over 48 weeks, average body weight fell by 24.2% in the highest-dose group, versus 2.1% on placebo (the inactive look-alike)

Studies in experimental animals have probed neural markers of these discrete reward processes, and these can be compared with imaging studies of anhedonic humans